HealthCor Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,536,760
Closed -$63.2M 68
2019
Q4
$63.2M Sell
2,536,760
-4,870
-0.2% -$98.7K 2.25% 15
2019
Q3
$43.2M Sell
2,541,630
-234,265
-8% -$4.26M 1.63% 26
2019
Q2
$63.2M Buy
2,775,895
+203,985
+8% +$5.5M 2.45% 15
2019
Q1
$82.7M Buy
2,571,910
+81,800
+3% +$2.53M 3.34% 11
2018
Q4
$70.2M Buy
2,490,110
+540,110
+28% +$15.8M 2.19% 19
2018
Q3
$56.1M Buy
1,950,000
+681,150
+54% +$20.5M 1.86% 24
2018
Q2
$47.5M Buy
1,268,850
+804,000
+173% +$31.6M 1.51% 27
2018
Q1
$18.3M Buy
+464,850
New +$17M 0.62% 41

Other funds holding XENT

HealthCor Management's XENT Position: Q1 2020 in Review

HealthCor Management sold out of Intersect ENT, Inc (XENT) in Q1 2020, closing a stake of 2,536,760 shares — an estimated $63.2M sold.

HealthCor Management first reported a position in XENT in Q1 2018 and held it in 8 quarters. The position peaked at $82.7M in Q1 2019. 121 funds tracked by Wall St. Rank hold XENT as of Q1 2020.

  • HealthCor Management reported no remaining Intersect ENT, Inc position as of Q1 2020 after selling out during the quarter.
  • HealthCor Management sold 2,536,760 Intersect ENT, Inc shares in Q1 2020, an estimated $63.2M.
  • HealthCor Management first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 8 quarters.
  • HealthCor Management's Intersect ENT, Inc position peaked at $82.7M in Q1 2019.
  • 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2020.

Based on HealthCor Management's 13F filing for Q1 2020, filed 15 May 2020.